Kala Bio KALA
NASDAQ KALA
$0.18 +0.02 (+12.46%)
As of: Nov 9, 2026 · 2:48 PM EST

Kala Bio (KALA) Sales of Property, Plant and Equipment (2021 - 2022)

Updated

Kala Bio's Sales of Property, Plant and Equipment came in at $47,000 for FY2023, down 58.8% from $114,000 in FY2022.

Analysis

Kala Bio (KALA) Sales of Property, Plant and Equipment (2021 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put Sales of Property, Plant and Equipment at $114,000 in FY2022 (+23.9%) and $92,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,264.91 Bn 1,238.52 Bn 20.46 Bn -
2 Johnson & Johnson 680.50 Bn 600.36 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.57 Bn 487.58 Bn 13.12 Bn -
4 Merck 366.94 Bn 329.88 Bn 13.19 Bn -
5 Novartis Ag 318.17 Bn 291.41 Bn - -
6 Astrazeneca 294.15 Bn 268.04 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.66 Bn 203.31 Bn 7.58 Bn -
8 Gilead Sciences 210.75 Bn 185.86 Bn 6.73 Bn -
9 Pfizer 168.26 Bn 115.62 Bn 12.56 Bn -
10 Kala Bio 2.69 Mn -41.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 73,000.00
Dec 31, 2021 42,000.00
API Access

Kala Bio Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=KALA&period=max&api_key=YOUR_API_KEY